Bruna Machado

Ms. Bruna Machado

UNIVERSIDADE FEDERA RIO GRANDE DO SUL, Porto Alegre, Rio Grande do Sul, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2024 in Animals
Verified
Journal Article
Open access
PDF file
ÁPÁlan Gomes Pöppl
Álan Gomes Pöppl
JLJosé Lucas Xavier Lopes
José Lucas Xavier Lopes
TNTaís Bock Nogueira
Taís Bock Nogueira
DSDenise Iparraguirre da Silva
Denise Iparraguirre da Silva
BMBruna Machado
Bruna Machado
Progesterone-related diabetes mellitus (PRDM) in dogs is known for its particular potential for diabetes remission. This narrative review aims to provide relevant detailed information on (1) the canine estrus cycle and its impact on canine diabetes mellitus (CDM) etiology and management, (2) the role of pyometra as a further cause of insulin resistance, and (3) useful individual therapeutic and preventive strategies. PRDM is recognized due to diestrus, exogenous progestogen exposure, pregnancy, and P4-production ovarian dysfunction. Pyometra represents additional inflammatory and septic negative influence on insulin sensitivity, and its diagnosis associated with CDM is therapeutically challenging. The estrus cycle’s hormone fluctuations seem to modulate peripheric insulin sensibility by influencing insulin receptor (IR) affinity and its binding capacity, as well as modulating tyrosine kinase activity. Pyometra was shown to negatively influence IR compensatory mechanisms to insulin resistance causing glucose intolerance. Spaying and pregnancy termination may cause diabetes remission in PRDM cases in a median time of 10 days (1–51). Pharmacological annulment of progesterone effects may benefit patients unable to undergo surgery; however, remission chances are virtually null. The ALIVE (Agreeing Language in Veterinary Endocrinology) project proposed new criteria for CDM diagnoses and subclinical diabetes recognition. These new concepts may increase the frequency of a PRDM diagnosis and, even more, its relevance. Spaying represents a preventive measure against pyometra and PRDM that should be individually assessed in light of its recognized benefits and harms.

1 December 2022 in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Verified
Journal Article
Open access
BMBruna Machado
Bruna Machado
CBC.E. Bruno
C.E. Bruno
DSD.I. Silva
D.I. Silva
JBJ.C. Barth
J.C. Barth
LSL.P. Santos
L.P. Santos
ÁPÁlan Gomes Pöppl
Álan Gomes Pöppl
Anecdotal reports suggest that the new coronavirus SARS-CoV-2 pandemic (COVID-19) has increased overweight and obesity prevalence in dogs and cats. The present report aimed to perform a retrospective overweight/obesity survey on 1,001 consecutive cases attended in the Veterinary Clinics Hospital from the Federal University of Rio Grande do Sul during its reopening to the public after months closed due to the pandemic. The overall overweight or obesity observed prevalence was 36.63%; being the frequency in cats slightly greater (38.37%) than compared to dogs (35.76%). No local increase in these frequencies was detected. Neutering (dogs and cats), age greater than 10 years (dogs), and male gender (cats) were factors associated with overweight/obesity. Bodyweight was not registered in about 30% of the medical records, while the body condition score was not registered in about 50% of the cases. These flaws were more often observed in feline medical records and efforts to improve these data records are warranted.

19 February 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
ÁPÁlan Gomes Pöppl
Álan Gomes Pöppl
JLJosé Lucas Xavier Lopes
José Lucas Xavier Lopes
TNTaís Bock Nogueira
Taís Bock Nogueira
DSDenise Iparraguirre Da Silva
Denise Iparraguirre Da Silva
BMBruna Machado
Bruna Machado
Correlations among estrus cycle, pyometra, and canine diabetes mellitus (CDM) have been described since the late 1950s, and substantial progress in understanding mechanisms beyond was achieved nowadays. Progesterone-related diabetes mellitus (PRDM) in dogs is known for its particular potential for diabetes remission. Thus, a deep understanding of the physiopathological aspects involved is crucial to postulate treatment guidelines to improve the PRDM remission rate, as well as to inform preventive measures. This narrative review aims to provide relevant detailed information on 1) canine estrus cycle and its impact on CDM etiology and management, 2) the role of pyometra as a further cause of insulin resistance, and 3) useful individual therapeutic and preventive strategies. Pharmacological annulment of progesterone effects, as well as inflammatory and progesterone-related conditions resolution in association with adequate exogenous insulin therapy, and residual beta cell function, are key aspects to achieve remission, or at least to improve diabetic clinical control. In this way, spaying should be considered mandatory in most PRDM cases. Preventive measures against CDM can include spaying recommendations; however, individual-based recommendations should be considered since castration may be associated with some long-term health issues.

24 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
JLJosé Lucas Xavier Lopes
José Lucas Xavier Lopes
TNTaís Bock Nogueira
Taís Bock Nogueira
LRLuana Rodrigues
Luana Rodrigues
VWVitória Strzeleski Wodzik
Vitória Strzeleski Wodzik
DSDenise Iparraguirre da Silva
Denise Iparraguirre da Silva
ÁPÁlan Gomes Pöppl
Álan Gomes Pöppl
Portable blood glucose meters (PBGMs) are essential for detecting glycemic disorders. In Brazil, veterinary devices are scarce, and human devices are used as an alternative. This study evaluated the accuracy of three human glucometers: Accu-Chek Guide® (ACG) and Accu-Chek Guide Me® (ACGM) (Roche), and EcoCheck® (EC) (Eco Diagnóstica). A total of 419 glycemic samples were collected and compared to the glucose oxidase method (GOM), considered the gold standard. Despite a strong positive correlation compared to the GOM (ACG r = 0.96; ACGM r = 0.9; EC r = 0.89; P <0.0001), when evaluated by the criteria defined by ISO15197:2013 for analytical precision, no PG obtained 99% of the readings within the range of +/- 15 for glucose levels 100mg/dL (ACG = 57.9%, ACGM = 47.9%, and EC = 28.4%). ACG was the only PG that fully met the clinical precision criteria according to ISO15197:2013, with 100% of its measurements in zones A+B of the error grid. Despite analytical inaccuracy, ACG PBGM proved to be the best among the devices tested in this study for use in dogs with whole blood samples, not generating any negative impact on animal health.

9 May 2025 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
JLJosé Lucas Xavier Lopes
José Lucas Xavier Lopes
TNTaís Bock Nogueira
Taís Bock Nogueira
LRLuana Rodrigues
Luana Rodrigues
VWVitória Strzeleski Wodzik
Vitória Strzeleski Wodzik
DSDenise Iparraguirre da Silva
Denise Iparraguirre da Silva
ÁPÁlan Gomes Pöppl
Álan Gomes Pöppl
Portable blood glucose meters (PBGMs) are essential for detecting glycemic disorders. In Brazil, veterinary devices are scarce, and human devices are used as an alternative. This study evaluated the accuracy of three human glucometers: Accu-Chek Guide® (ACG), Accu-Chek Guide Me® (ACGM) (Roche), and EcoCheck® (EC) (Eco Diagnóstica). A total of 419 glycemic samples were collected and compared to the glucose oxidase method (GOM), which is considered to be the gold standard. Despite a strong positive correlation compared to the GOM (ACG r = 0.96; ACGM r = 0.9; EC r = 0.89; p < 0.0001), when evaluated by the criteria defined by ISO 15197:2013 for analytical precision, no PG obtained 99% of the readings within the range of +/− 15 for glucose levels < 100 mg/dL and +/− 15% for glucose levels > 100 mg/dL (ACG = 57.9%, ACGM = 47.9%, and EC = 28.4%). ACG was the only PG that fully met the clinical precision criteria according to ISO 15197:2013, with 100% of its measurements in Zones A+B of the error grid. Despite analytical inaccuracy, the ACG PBGM proved to be the best among the devices tested in this study for use in dogs with whole blood samples, not generating any negative impact on animal health.

1 January 2024 in Pesquisa Veterinária Brasileira
Verified
Journal Article
Open access
PDF file
JDJanyni Duz
Janyni Duz
LSLívia E. Surita
Lívia E. Surita
LMLetícia Machado
Letícia Machado
PCPriscila M.D. Costa
Priscila M.D. Costa
BMBruna Machado
Bruna Machado
ÁPÁlan Gomes Pöppl
Álan Gomes Pöppl
Type-2 diabetes mellitus (T2DM) is characterized by defects in insulin secretion and combined peripheral resistance to the hormone. Several non-human primates (NHP) species develop T2DM, mainly captive animals with reduced physical activity and incorrect feeding. This case report describes the T2DM treatment of a black-eared marmoset (Callithrix penicillata) by diet reformulation and metformin oral administration. An adult female was diagnosed with T2DM after hyperglycemia and high serum fructosamine associated with glycosuria and obesity. Metformin hydrochloride (125mg/animal, orally, q24h) associated with feeding intervention was started. After 26 days, a significant reduction in weight, glycemia, and serum fructosamine could be observed, showing satisfactory results for the adopted therapy. Metformin is considered a safe drug for T2DM treatment due to its low hypoglycemia risk. The new diet consisted of sweet potato, squash, and varied fruits offered twice daily. In addition, thawed-mice newborns, egg whites, and small portions of pelleted primate food. In the present report, metformin use, associated with a low glycemic index diet, was effective in treating this particular marmoset and may present a potential for T2DM treatment in other NHPs.